1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the
Study
2.2. Baseline Methodology
2.3. Key Industry
Partners
2.4. Major Association
and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data Triangulation
& Validation
2.7. Assumptions and
Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, and Trends
4. Voice of Customer
5.
Global Therapeutic Drug Monitoring Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share &
Forecast
5.2.1. By Product (Consumables,
Equipment’s, Immunoassay Analyzers, Chromatography & MS Detector, Clinical
Chemistry Analyzers)
5.2.2. By Technology
(Immunoassay, Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence,
Immunoassay, Radioimmunoassay, others Immunoassay, chromatography-MS, LC-MS,
GC-MS)
5.2.3. By Class of Drug
(Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic
Drug, Bronchodilator Drug, Psychoactive Drug, and others)
5.2.4. By End User
(Hospital Lab, Commercial & Private Lab, others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Product Map
5.3.1. By Type
5.3.2. By End-use
6.
North America Therapeutic Drug Monitoring Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Product (Consumables,
Equipment’s, Immunoassay Analyzers, Chromatography & MS Detector, Clinical
Chemistry Analyzers)
6.2.2. By Technology
(Immunoassay, Chemiluminescence Immunoassay, Colorimetric Immunoassay,
Fluorescence, Immunoassay, Radioimmunoassay, others Immunoassay,
chromatography-MS, LC-MS, GC-MS)
6.2.3. By Class of Drug
(Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic
Drug, Bronchodilator Drug, Psychoactive Drug, and others)
6.2.4. By End User
(Hospital Lab, Commercial & Private Lab, others)
6.2.5. By Country
6.3. North America:
Country Analysis
6.3.1. United States Therapeutic
Drug Monitoring Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By
Product
6.3.1.2.2.
By
Technology
6.3.1.2.3.
By class
of Drug
6.3.1.2.4.
By End-
User
6.3.2. Canada Therapeutic
Drug Monitoring Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By
Product
6.3.2.2.2.
By
Technology
6.3.2.2.3.
By class
of Drug
6.3.2.2.4.
By End-
User
6.3.3. Mexico Therapeutic
Drug Monitoring Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By
Product
6.3.3.2.2.
By
Technology
6.3.3.2.3.
By class
of Drug
6.3.3.2.4.
By End-
User
7.
Europe Therapeutic Drug Monitoring Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Product (Consumables,
Equipment’s, Immunoassay Analyzers, Chromatography & MS Detector, Clinical
Chemistry Analyzers)
7.2.2. By Technology
(Immunoassay, Chemiluminescence Immunoassay, Colorimetric Immunoassay,
Fluorescence, Immunoassay, Radioimmunoassay, others Immunoassay,
chromatography-MS, LC-MS, GC-MS)
7.2.3. By Class of Drug
(Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic
Drug, Bronchodilator Drug, Psychoactive Drug, and others)
7.2.4. By End User
(Hospital Lab, Commercial & Private Lab, others)
7.2.5. By Country
7.3. Europe: Country
Analysis
7.3.1. France Therapeutic
Drug Monitoring Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By
Product
7.3.1.2.2.
By
Technology
7.3.1.2.3.
By class
of Drug
7.3.1.2.4.
By End-
User
7.3.2. United Kingdom Therapeutic
Drug Monitoring Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By
Product
7.3.2.2.2.
By Technology
7.3.2.2.3.
By class
of Drug
7.3.2.2.4.
By End-
User
7.3.3. Italy Therapeutic
Drug Monitoring Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By
Product
7.3.3.2.2.
By
Technology
7.3.3.2.3.
By class
of Drug
7.3.3.2.4.
By End-
User
7.3.4. Germany Therapeutic
Drug Monitoring Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By
Product
7.3.4.2.2.
By
Technology
7.3.4.2.3.
By class
of Drug
7.3.4.2.4.
By End-
User
7.3.5. Spain Therapeutic
Drug Monitoring Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By
Product
7.3.5.2.2.
By
Technology
7.3.5.2.3.
By class
of Drug
7.3.5.2.4.
By End-
User
8.
Asia-Pacific Therapeutic Drug Monitoring Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Product (Consumables,
Equipment’s, Immunoassay Analyzers, Chromatography & MS Detector, Clinical
Chemistry Analyzers)
8.2.2. By Technology
(Immunoassay, Chemiluminescence Immunoassay, Colorimetric Immunoassay,
Fluorescence, Immunoassay, Radioimmunoassay, others Immunoassay,
chromatography-MS, LC-MS, GC-MS)
8.2.3. By Class of Drug
(Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic
Drug, Bronchodilator Drug, Psychoactive Drug, and others)
8.2.4. By End User
(Hospital Lab, Commercial & Private Lab, others)
8.2.5. By Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China Therapeutic
Drug Monitoring Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By
Product
8.3.1.2.2.
By
Technology
8.3.1.2.3.
By class
of Drug
8.3.1.2.4.
By End-
User
8.3.2. India Therapeutic
Drug Monitoring Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By
Product
8.3.2.2.2.
By
Technology
8.3.2.2.3.
By class
of Drug
8.3.2.2.4.
By End-
User
8.3.3. Japan Therapeutic
Drug Monitoring Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By
Product
8.3.3.2.2.
By
Technology
8.3.3.2.3.
By class
of Drug
8.3.3.2.4.
By End-
User
8.3.4. South Korea
Therapeutic Drug Monitoring Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By
Product
8.3.4.2.2.
By
Technology
8.3.4.2.3.
By class
of Drug
8.3.4.2.4.
By End-
User
8.3.5. Australia Therapeutic
Drug Monitoring Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By
Product
8.3.5.2.2.
By
Technology
8.3.5.2.3.
By class
of Drug
8.3.5.2.4.
By End-
User
9.
South America Therapeutic Drug Monitoring Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Product (Consumables,
Equipment’s, Immunoassay Analyzers, Chromatography & MS Detector, Clinical
Chemistry Analyzers)
9.2.2. By Technology
(Immunoassay, Chemiluminescence Immunoassay, Colorimetric Immunoassay,
Fluorescence, Immunoassay, Radioimmunoassay, others Immunoassay,
chromatography-MS, LC-MS, GC-MS)
9.2.3. By Class of Drug
(Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic
Drug, Bronchodilator Drug, Psychoactive Drug, and others)
9.2.4. By End User
(Hospital Lab, Commercial & Private Lab, others)
9.2.5. By Country
9.3. South America:
Country Analysis
9.3.1. Brazil Therapeutic
Drug Monitoring Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By
Product
9.3.1.2.2.
By
Technology
9.3.1.2.3.
By class
of Drug
9.3.1.2.4.
By End-
User
9.3.2. Argentina Therapeutic
Drug Monitoring Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By
Product
9.3.2.2.2.
By
Technology
9.3.2.2.3.
By class
of Drug
9.3.2.2.4.
By End-
User
9.3.3. Colombia Therapeutic
Drug Monitoring Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By
Product
9.3.3.2.2.
By
Technology
9.3.3.2.3.
By class
of Drug
9.3.3.2.4.
By End-
User
10.
Middle East and Africa Therapeutic Drug Monitoring Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Product (Consumables,
Equipment’s, Immunoassay Analyzers, Chromatography & MS Detector, Clinical
Chemistry Analyzers)
10.2.2. By Technology
(Immunoassay, Chemiluminescence Immunoassay, Colorimetric Immunoassay,
Fluorescence, Immunoassay, Radioimmunoassay, others Immunoassay,
chromatography-MS, LC-MS, GC-MS)
10.2.3. By Class of Drug
(Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic
Drug, Bronchodilator Drug, Psychoactive Drug, and others)
10.2.4. By End User
(Hospital Lab, Commercial & Private Lab, others)
10.2.5. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Therapeutic
Drug Monitoring Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By
Product
10.3.1.2.2.
By
Technology
10.3.1.2.3.
By class
of Drug
10.3.1.2.4.
By End-
User
10.3.2. UAE Therapeutic Drug
Monitoring Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By
Product
10.3.2.2.2.
By
Technology
10.3.2.2.3.
By class
of Drug
10.3.2.2.4.
By End-
User
10.3.3. Saudi Arabia Therapeutic
Drug Monitoring Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By
Product
10.3.3.2.2.
By
Technology
10.3.3.2.3.
By class
of Drug
10.3.3.2.4.
By End-
User
10.3.4. Turkey Therapeutic
Drug Monitoring Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By
Product
10.3.4.2.2.
By
Technology
10.3.4.2.3.
By class
of Drug
10.3.4.2.4.
By End-
User
10.3.5. Egypt Therapeutic
Drug Monitoring Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1.
By
Product
10.3.5.2.2.
By
Technology
10.3.5.2.3.
By class
of Drug
10.3.5.2.4.
By End-
User
11. Market Dynamics
11.1.
Drivers
11.1.1. Use of Therapeutic
Monitoring in Organ Transplant.
11.1.2. Prevalence of
Autoimmune Diseases
11.1.3. Rise in the adoption
of technologically advanced tool in the healthcare industry
11.2.
Challenges
11.2.1.
Lack of skilled labor
11.2.2. Limited medical workforce
11.2.3. Unpredictable and
unforeseeable activities
12. Market Trends &
Developments
12.1.
Product Launches
12.2.
Mergers & Acquisitions
12.3.
Technological Advancements
13. Global Therapeutic
Drug Monitoring Market: SWOT Analysis
14. Competitive
Landscape
14.1.
Roche AG
14.1.1. Business Overview
14.1.2. Product Offerings
14.1.3. Recent Developments
14.1.4. Financials (In Case
of Listed Companies)
14.1.5. Key Personnel
14.1.6.
SWOT Analysis
14.2.
Siemens Healthcare GmbH
14.3.
Thermo Fisher Scientific, Inc.
14.4.
Bio-Rad Laboratories, Inc.
14.5.
Beckman Coulter, Inc.
14.6.
Abbott Laboratories, Inc.
14.7.
Agilent Technologies, Inc.
14.8.
bioMérieux, Inc.
14.9.
Alere, Inc.
Strategic Recommendations